Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Lonnie M. Smith sold 225 shares of the business’s stock in a transaction dated Wednesday, November 7th. The shares were sold at an average price of $540.04, for a total transaction of $121,509.00. Following the completion of the transaction, the director now owns 379,175 shares in the company, valued at $204,769,667. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of ISRG stock traded down $6.35 during trading hours on Thursday, reaching $539.33. 42,199 shares of the company were exchanged, compared to its average volume of 1,093,480. Intuitive Surgical, Inc. has a fifty-two week low of $359.75 and a fifty-two week high of $581.12. The firm has a market capitalization of $59.35 billion, a price-to-earnings ratio of 75.09, a PEG ratio of 3.49 and a beta of 1.02.
Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.17. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. The company had revenue of $920.90 million for the quarter, compared to analyst estimates of $916.22 million. During the same period in the prior year, the business earned $2.77 earnings per share. Intuitive Surgical’s quarterly revenue was up 14.0% on a year-over-year basis. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 9.52 earnings per share for the current year.
A number of research firms have commented on ISRG. Piper Jaffray Companies boosted their price target on shares of Intuitive Surgical from $613.00 to $625.00 and gave the company an “overweight” rating in a research report on Wednesday, October 31st. BTIG Research restated a “hold” rating on shares of Intuitive Surgical in a research report on Sunday, October 21st. Royal Bank of Canada restated a “hold” rating and issued a $560.00 price target on shares of Intuitive Surgical in a research report on Friday, October 19th. Raymond James boosted their price target on shares of Intuitive Surgical from $620.00 to $630.00 and gave the company an “outperform” rating in a research report on Friday, October 19th. Finally, Canaccord Genuity upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and boosted their price target for the company from $550.00 to $610.00 in a research report on Friday, October 19th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and seventeen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $554.64.
COPYRIGHT VIOLATION WARNING: “Intuitive Surgical, Inc. (ISRG) Director Sells $121,509.00 in Stock” was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at https://sportsperspectives.com/2018/11/08/intuitive-surgical-inc-isrg-director-sells-121509-00-in-stock.html.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Recommended Story: What is the Dividend Aristocrat Index?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.